@article{581fad79e30b45aaa14016f00768b82f,
title = "Pharmacological management of treatment-induced insomnia in ADHD",
author = "Kratochvil, {Christopher J.} and Marybeth Lake and Pliszka, {Steven R.} and Walkup, {John T.}",
note = "Funding Information: Disclosure: Dr. Kratochvil receives grant support from or is a consultant to or member of the speaker's bureau of AstraZeneca, Eli Lilly and Company, GlaxoSmithKline, Forest, Cephalon, McNeil Pharmaceutical, Novartis Pharmaceutical, and Organon; Dr. Lake receives grant support from or is a member of the speaker's bureau of AstraZeneca, Johnson & Johnson, and McNeil Pharmaceutical. Dr. Pliszka receives support from or is a member of the speaker's bureau of Eli Lilly and Company, Shire Laboratories Inc., and McNeil Pharmaceutical; and Dr. Walkup receives grant support from or is a consultant or member of the speaker's bureau for Abbott, Eli Lilly and Company, Janssen Pharmaceutical, and Pfizer. ",
year = "2005",
month = may,
doi = "10.1097/01.chi.0000155322.32500.3a",
language = "English (US)",
volume = "44",
pages = "499--501",
journal = "Journal of the American Academy of Child and Adolescent Psychiatry",
issn = "0890-8567",
publisher = "Elsevier Limited",
number = "5",
}